← Insider buys
EWTX

Edgewise Therapeutics, Inc. · Healthcare

Orbimed Advisors LLC bought $5.0M of Edgewise Therapeutics, Inc.

Director and 10% owner

Bought$4,999,999
$10.32Price
484,496Shares
+4%Stake

What EWTX did for a copier

Filed Sep 16Copier in Sep 19
$1,000 copied at Mon, Sep 19 open, $9.81
$969
S&P 500, same days
+1.0%

Measured over 30 trading days, to the Oct 31 close.

Orbimed Advisors LLC's record

34 other buys with 3 months of prices since 2016: on average −12.3% against the S&P 500, and 12 of 34 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Fri, Sep 16. Filed Fri, Sep 16, 4:31 PM ET, after the close. Returns use the Sep 19 open and the Oct 31 close. Not investment advice.